Etelcalcetide Alternatives Compared
| Etelcalcetide | Parsabiv (etelcalcetide) | Rayaldee (calcifediol) |
|
|---|
| Etelcalcetide | Parsabiv (etelcalcetide) | Rayaldee (calcifediol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hyperparathyroidism Secondary to Renal Impairment. Etelcalcetide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperparathyroidism Secondary to Renal Impairment. Parsabiv may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperparathyroidism Secondary to Renal Impairment. Rayaldee may also be used for purposes not listed in this medication guide. |
Related suggestions Hyperparathyroidism Secondary to Renal Impairment
|
|||||||||||||||
| More about Etelcalcetide | More about Parsabiv (etelcalcetide) | More about Rayaldee (calcifediol) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Rayaldee has an average rating of 7.9 out of 10 from a total of 7 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Etelcalcetide side effects |
View all Parsabiv side effects |
View all Rayaldee side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Parsabiv prices |
View all Rayaldee prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Parsabiv |
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
96 hours |
96 hours |
528 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 21 drugs are known to interact with Etelcalcetide:
|
A total of 21 drugs are known to interact with Parsabiv:
|
A total of 90 drugs are known to interact with Rayaldee:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
February 07, 2017 |
February 07, 2017 |
June 17, 2016 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.